PyInvesting

Market research

CBHD.F Coloplast A/S

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
14B
P/E ratio
36.95
Analyst target
19.05
Dividend yield
39.%
Beta
0.55

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Coloplast A/S is currently in a long term uptrend where the price is trading 13.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.0.

Coloplast A/S's total revenue rose by 0.6% to $5B since the same quarter in the previous year.

Its net income has increased by 4.0% to $1B since the same quarter in the previous year.

Finally, its free cash flow grew by 18.6% to $957M since the same quarter in the previous year.

Based on the above factors, Coloplast A/S gets an overall score of 5/5.